Home biopharmaceuticals
 

Keywords :   


Tag: biopharmaceuticals

Navidea Biopharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference

2013-04-02 03:59:33| Biotech - Topix.net

Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr.

Tags: present future industry conference

 

SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies

2013-03-27 14:56:00| dairynetwork Home Page

The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder.

Tags: development companies chinese drug

 
 

SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies

2013-03-27 14:56:00| dairynetwork News Articles

The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder.

Tags: development companies chinese drug

 

SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies

2013-03-27 14:56:00| drugdiscoveryonline News Articles

The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder

Tags: development companies chinese drug

 

Development & Commercial Services: Biopharmaceuticals

2013-03-06 16:24:48| drugdiscoveryonline Downloads

From having developed over 80 large molecule dose forms, Patheon has extensive experience ranging from early formulation development through to product commercialization. Product development is supported by robust site infrastructure including Bioanalytical laboratories (including cell-based assays) and storage of refrigerated and frozen drug products (-20°C and -70°C). Liquid and lyophilized products are effectively managed using minimal amounts of API.

Tags: services development commercial commercial development

 

Sites : [1] [2] [3] [4] [5] next »